A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
Leeat Keren(Weizmann Institute of Science), Michael Angelo(Stanford University), David Van Valen(California Institute of Technology), Sean C. Bendall(Stanford University), Soo‐Ryum Yang(Memorial Sloan Kettering Cancer Center), Allison W. Kurian(Stanford University), Sushama Varma(Stanford University), Diana M. Marquez(Stanford University), Roshan Angoshtari(Stanford University), Marc Bossé(Stanford University), Samir Jain(Stanford University), Robert B. West(Stanford University)
Cited by 1,185
Related Papers
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862
The Novel Marker, DOG1, Is Expressed Ubiquitously in Gastrointestinal Stromal Tumors Irrespective of KIT or PDGFRA Mutation Status
|American Journal Of Pathology|2004|662
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
|Journal of the National Comprehensive Cancer Network|2016|660